Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jessika Suescun
Observed names:
J. Gomez Suescun,
J. Suescun,
Jessika S. Ocampo,
Suescun, J.,
Suescun, Jessika
Institution:
Queensland University of Technology
Observed institutions:
Roswell Park Comprehensive Cancer Center,
Translational Research Institute,
Queensland University of Technology,
Neurology, Inc,
The University of Texas Health Science Center at Houston
ORCID:
0000-0003-3936-3936
Observed ORCID:
0000-0003-3936-3936
OpenAlex ID:
A5083078809
Fecal microbiota transplantation in Parkinson's disease—A randomized repeat-dose, placebo-controlled clinical pilot study
2023
·
Herbert L. DuPont
, Jessika Suescun
, et al.
·
Frontiers in Neurology
·
159
PDF
Progression of clinical markers in prodromal Parkinson’s disease and dementia with Lewy bodies: a multicentre study
2023
·
Stephen Joza
, Michele T Hu
, et al.
·
Brain
·
131
PDF
Altered Nigrostriatal and Nigrocortical Functional Connectivity in Rapid Eye Movement Sleep Behavior Disorder
2013
·
Timothy M. Ellmore
, Richard J. Castriotta
, et al.
·
SLEEP
·
108
Allogeneic Bone Marrow–Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson's Disease
2021
·
Mya Schiess
, Jessika Suescun
, et al.
·
Movement Disorders
·
67
Earlier Intervention with Deep Brain Stimulation for Parkinson’s Disease
2017
·
Gerson Suarez-Cedeno
, Jessika Suescun
, et al.
·
Parkinson s Disease
·
40
PDF
The Role of Neuroinflammation in Neurodegenerative Disorders
2018
·
Jessika Suescun
, Shivika Chandra
, et al.
·
Elsevier eBooks
·
34
Computational medication regimen for Parkinson’s disease using reinforcement learning
2021
·
Yejin Kim
, Jessika Suescun
, et al.
·
Scientific Reports
·
26
PDF
Slowed Prosaccades and Increased Antisaccade Errors As a Potential Behavioral Biomarker of Multiple System Atrophy
2017
·
Sarah H. Brooks
, Eliana M. Klier
, et al.
·
Frontiers in Neurology
·
26
PDF
Serum Lymphocyte-Associated Cytokine Concentrations Change More Rapidly over Time in Multiple System Atrophy Compared to Parkinson Disease
2016
·
Keri Csencsits-Smith
, Jessika Suescun
, et al.
·
NeuroImmunoModulation
·
26
Longitudinal Connectomes as a Candidate Progression Marker for Prodromal Parkinson’s Disease
2019
·
Óscar Peña-Nogales
, Timothy M. Ellmore
, et al.
·
Frontiers in Neuroscience
·
25
PDF
A Study of the Relationship Between Uric Acid and Substantia Nigra Brain Connectivity in Patients With REM Sleep Behavior Disorder and Parkinson's Disease
2020
·
Timothy M. Ellmore
, Jessika Suescun
, et al.
·
Frontiers in Neurology
·
24
PDF
Updated Parkinson's disease motor subtypes classification and correlation to cerebrospinal homovanillic acid and 5-hydroxyindoleacetic acid levels
2023
·
Christopher Adams
, Jessika Suescun
, et al.
·
Clinical Parkinsonism & Related Disorders
·
23
Quantifying Neurodegenerative Progression With DeepSymNet, an End-to-End Data-Driven Approach
2019
·
Danilo Pena
, Arko Barman
, et al.
·
Frontiers in Neuroscience
·
15
PDF
Toward a Multimodal Computer-Aided Diagnostic Tool for Alzheimer’s Disease Conversion
2022
·
Danilo Pena
, Jessika Suescun
, et al.
·
Frontiers in Neuroscience
·
12
PDF
Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial
2025
·
Mya C. Schiess
, Jessika Suescun
, et al.
·
Movement Disorders
·
11
PDF
IgA-Biome Profiles Correlate with Clinical Parkinson’s Disease Subtypes
2023
·
Eric L. Brown
, Heather T. Essigmann
, et al.
·
Journal of Parkinson s Disease
·
7
Clinical Determinants of Progression of Parkinson Disease
2015
·
Mya Caryn Schiess
, Jessika Suescun
·
JAMA Neurology
·
7
Allogeneic bone marrow-derived mesenchymal stem cells in the aging kidney: secondary results of a Parkinson’s disease clinical trial
2025
·
Juan D. Martinez-Lemus
, Donald A. Molony
, et al.
·
Stem Cell Research & Therapy
·
5
PDF
Longitudinal connectome-based predictive modeling for REM sleep behavior disorder from structural brain connectivity
2018
·
Luca Giancardo
, Timothy Ellmore
, et al.
·
SPIE Medical Imaging: Computer-Aided Diagnosis
·
4
Microbiome characterization and reversal of dysbiosis in Parkinson’s disease by Fecal Microbiota Transplantation (1825)
2020
·
Herbert L. DuPont
, Jessika Suescun
, et al.
·
Neurology
·
3
REM Sleep Behavior Disorder: a Prodromal Synucleinopathy
2016
·
Jessika Suescun
, Timothy M. Ellmore
, et al.
·
Current Geriatrics Reports
·
3
Role of alpha-synuclein seed amplification assay in Parkinson’s disease clinical trials: A case of misdiagnosis
2024
·
Emily Tharp
, Juan D. Martinez-Lemus
, et al.
·
Clinical Parkinsonism & Related Disorders
·
2
Blood microRNA-7 as a Progression Biomarker in men with Parkinson's disease (S37.006)
2023
·
Mya Schiess
, Jessika Suescun
, et al.
·
Neurology
·
2
Retrospective longitudinal analysis of blood microRNA-7-5p as a possible progression biomarker in people with Parkinson’s disease
2026
·
Shayan Abdollah Zadegan
, Corrine Hutchinson
, et al.
·
Frontiers in Neuroscience
·
1
PDF
Design and Baseline characteristic of Phase II clinical trial of allogeneic bone marrow-derived Mesenchymal Stem Cells as a disease-modifying therapy for idiopathic Parkinson’s disease (P1-11.004)
2023
·
Mya Schiess
, Timothy Ellmore
, et al.
·
Neurology
·
1
Show more works
View as search
Works count:
46
Citation count:
766
H-index:
13
I10-index:
15
Year
Topic
Type